Invention Grant
- Patent Title: Molecules inhibiting the human immunodeficiency virus type 1 (HIV-1), method for the production thereof and applications of same
-
Application No.: US14646573Application Date: 2013-11-22
-
Publication No.: US09938532B2Publication Date: 2018-04-10
- Inventor: Alfredo Berzal Herranz , Carlos Briones Llorente , Francisco José Sánchez-Luque , Susanna Cuevas Manrubia , Michael Stich
- Applicant: CONSEJO SUPERIOR DE INVESTIGACIONES CIENTÍFICAS (CSIC) , INSTITUTO NACIONAL DE TÉCNICA AEROESPACIAL “ESTEBAN TERRADAS”
- Applicant Address: ES Madrid ES Madrid
- Assignee: CONSEJO SUPERIOR DE INVESTIGACIONES CIENTÍFICAS (CSIC),INSTITUTO NACIONAL DE TÉCNICA AEROESPACIAL “ESTEBAN TERRADAS”
- Current Assignee: CONSEJO SUPERIOR DE INVESTIGACIONES CIENTÍFICAS (CSIC),INSTITUTO NACIONAL DE TÉCNICA AEROESPACIAL “ESTEBAN TERRADAS”
- Current Assignee Address: ES Madrid ES Madrid
- Agency: Wenderoth, Lind & Ponack, L.L.P.
- Priority: ES201231819 20121123
- International Application: PCT/ES2013/070809 WO 20131122
- International Announcement: WO2014/080061 WO 20140530
- Main IPC: C12N15/115
- IPC: C12N15/115 ; C12N15/10 ; G01N33/569

Abstract:
The invention relates to an aptamer, the structure thereof comprising at least one nucleotide sequence 5′-GGCA(A/G)GGA-3′, that can specifically bind to the poly(A) hairpin of the 5′UTR region of the genome of the human immunodeficiency virus type 1 (HIV-1), providing the method for producing aptamers with said sequence by means of a combination of experimental techniques of in vitro selection of nucleic acids with computational techniques of sequence optimization. The invention also relates to a DNA gene structure for synthesizing said aptamers, preferably RNA. The invention further relates to the different uses of the above-mentioned aptamer, including the use thereof as a biosensor molecule for detecting and/or quantifying HIV-1, as an inhibitor of the production of viral particles of HIV-1, and to the application thereof in medicine, the invention also relating to a method for treating a disease caused by HIV-1, and to a pharmaceutical composition comprising said aptamer.
Public/Granted literature
Information query
IPC分类: